| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.4M | — | +65.7% |
| Cost of Revenue | $3.5M | — | -5.0% |
| R&D Expense | $4.2M | — | -21.6% |
| SG&A Expense | $11.0M | — | -42.4% |
| Operating Income | -$4.2M | — | +78.3% |
| Pre-tax Income | -$8.1M | — | +64.9% |
| Income Tax | $0 | — | — |
| Net Income | -$8.1M | — | +64.9% |
| EPS (Basic) | -$0.07 | — | +70.8% |
| EPS (Diluted) | -$0.07 | — | +70.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $110.7M | -8.6% | +61.3% |
| Accounts Receivable | $6.9M | -61.3% | — |
| Inventory | $8.1M | +30.8% | +12.1% |
| Current Assets | $130.2M | -12.8% | +46.0% |
| Total Assets | $141.1M | -12.0% | +38.0% |
| Current Liabilities | $31.8M | -33.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$14.8M | — | +36.7% |
| Capital Expenditures | $52K | — | -61.5% |
| Investing Cash Flow | -$52K | — | +61.5% |
| Financing Cash Flow | $4.4M | — | -78.6% |
| Free Cash Flow | -$14.9M | — | +36.9% |
| +73.5% |
| Long-term Debt | $45.0M | +0.0% | +0.0% |
| Total Liabilities | $175.2M | -9.7% | +7.4% |
| Stockholders' Equity | -$34.1M | -1.2% | +44.1% |